{"id":"https://openalex.org/W2941650108","doi":"https://doi.org/10.1089/hum.2018.189","title":"An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA","display_name":"An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA","alternate_titles":[],"publication_year":2019,"publication_date":"2019-09-01","ids":{"openalex":"https://openalex.org/W2941650108","doi":"https://doi.org/10.1089/hum.2018.189","mag":"2941650108","pmid":"https://pubmed.ncbi.nlm.nih.gov/31020862"},"language":"en","primary_location":{"id":"doi:10.1089/hum.2018.189","doi":"https://doi.org/10.1089/hum.2018.189","is_oa":false,"landing_page_url":"https://doi.org/10.1089/hum.2018.189","pdf_url":null,"source":{"id":"https://openalex.org/S39730559","display_name":"Human Gene Therapy","issn_l":"1043-0342","issn":["1043-0342","1557-7422"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2941650108"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://research.manchester.ac.uk/en/publications/e26cffa3-2476-4943-8c60-91e3bbe17574","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039588510","display_name":"Anna L. Gray","orcid":"https://orcid.org/0000-0003-0182-8355","observed_orcids":["https://orcid.org/0000-0003-0182-8355"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna L. Gray","raw_affiliation_strings":["Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090642915","display_name":"Claire O\u2019Leary","orcid":"https://orcid.org/0000-0001-8616-7466","observed_orcids":["https://orcid.org/0000-0001-8616-7466"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claire O'Leary","raw_affiliation_strings":["Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108515941","display_name":"Aiyin Liao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aiyin Liao","raw_affiliation_strings":["Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103537056","display_name":"Leticia Ag\u00fandez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leticia Ag\u00fandez","raw_affiliation_strings":["Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026086965","display_name":"Amir Saam Youshani","orcid":"https://orcid.org/0000-0002-0256-3400","observed_orcids":["https://orcid.org/0000-0002-0256-3400"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amir S. Youshani","raw_affiliation_strings":["Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069137050","display_name":"H\u00e9l\u00e8ne F.E. Gleitz","orcid":"https://orcid.org/0000-0001-6138-8916","observed_orcids":["https://orcid.org/0000-0001-6138-8916"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H\u00e9l\u00e8ne F. Gleitz","raw_affiliation_strings":["Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081700202","display_name":"Helen Parker","orcid":"https://orcid.org/0000-0001-7324-9710","observed_orcids":["https://orcid.org/0000-0001-7324-9710"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helen Parker","raw_affiliation_strings":["Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012336418","display_name":"Jessica Taylor","orcid":"https://orcid.org/0000-0001-8565-8589","observed_orcids":["https://orcid.org/0000-0001-8565-8589"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jessica T. Taylor","raw_affiliation_strings":["Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105416523","display_name":"Olivier Danos","orcid":"https://orcid.org/0000-0003-2202-4540","observed_orcids":["https://orcid.org/0000-0003-2202-4540"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olivier Danos","raw_affiliation_strings":["Lysogene, Neuilly-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lysogene, Neuilly-sur-Seine, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075323202","display_name":"Micha\u00ebl Hocquemiller","orcid":"https://orcid.org/0000-0003-2654-7250","observed_orcids":["https://orcid.org/0000-0003-2654-7250"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Micha\u00ebl Hocquemiller","raw_affiliation_strings":["Lysogene, Neuilly-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lysogene, Neuilly-sur-Seine, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033356513","display_name":"Nuria Palomar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nuria Palomar","raw_affiliation_strings":["Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103442111","display_name":"R. Michael Linden","orcid":"https://orcid.org/0000-0002-9035-9070","observed_orcids":["https://orcid.org/0000-0002-9035-9070"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Michael Linden","raw_affiliation_strings":["Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059124764","display_name":"Els Henckaerts","orcid":"https://orcid.org/0000-0002-4624-7856","observed_orcids":["https://orcid.org/0000-0002-4624-7856"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Els Henckaerts","raw_affiliation_strings":["Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066450467","display_name":"Rebecca J. Holley","orcid":"https://orcid.org/0000-0003-4150-3299","observed_orcids":["https://orcid.org/0000-0003-4150-3299"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rebecca J. Holley","raw_affiliation_strings":["Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060376569","display_name":"Brian Bigger","orcid":"https://orcid.org/0000-0002-9708-1112","observed_orcids":["https://orcid.org/0000-0002-9708-1112"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Brian W. Bigger","raw_affiliation_strings":["Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, Manchester, United Kingdom","institution_ids":["https://openalex.org/I28407311"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5060376569"],"corresponding_institution_ids":["https://openalex.org/I28407311"],"apc_list":null,"apc_paid":null,"fwci":2.5108,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.88418568,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"30","issue":"9","first_page":"1052","last_page":"1066"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.0575999990105629,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adeno-associated-virus-vectors","display_name":"adeno-associated virus vectors","score":0.7749999761581421},{"id":"https://openalex.org/keywords/sumf1","display_name":"SUMF1","score":0.925000011920929},{"id":"https://openalex.org/keywords/promoter-replacement","display_name":"promoter replacement","score":0.460999995470047},{"id":"https://openalex.org/keywords/cag-promoter","display_name":"CAG promoter","score":0.8370000123977661},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.460999995470047},{"id":"https://openalex.org/keywords/lysosomal-storage-disorders","display_name":"lysosomal storage disease","score":0.9359999895095825},{"id":"https://openalex.org/keywords/heparan-sulfate","display_name":"heparan sulfate","score":0.8510000109672546},{"id":"https://openalex.org/keywords/intracranial-injection","display_name":"intracranial injection","score":0.828000009059906},{"id":"https://openalex.org/keywords/vector-biodistribution","display_name":"vector biodistribution","score":0.9240000247955322},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.5789999961853027},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C2779416428","wikidata":"https://www.wikidata.org/wiki/Q1479681","display_name":"Mucopolysaccharidosis","level":2,"score":0.6912822723388672},{"id":"https://openalex.org/C2778107364","wikidata":"https://www.wikidata.org/wiki/Q355989","display_name":"Adeno-associated virus","level":5,"score":0.6619147658348083},{"id":"https://openalex.org/C2778041096","wikidata":"https://www.wikidata.org/wiki/Q424668","display_name":"Heparan sulfate","level":3,"score":0.6118850708007812},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.5721392631530762},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.5122186541557312},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.49246105551719666},{"id":"https://openalex.org/C2778264360","wikidata":"https://www.wikidata.org/wiki/Q675010","display_name":"Lysosomal storage disease","level":3,"score":0.4352726936340332},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42713674902915955},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.383552223443985},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38124319911003113},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2667499780654907},{"id":"https://openalex.org/C153074725","wikidata":"https://www.wikidata.org/wiki/Q407553","display_name":"Glycosaminoglycan","level":2,"score":0.22267934679985046},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18429753184318542},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.15695226192474365},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000229","descriptor_name":"Dependovirus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005455","descriptor_name":"Fluorescent Antibody Technique","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006867","descriptor_name":"Hydrolases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009084","descriptor_name":"Mucopolysaccharidosis III","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009084","descriptor_name":"Mucopolysaccharidosis III","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009084","descriptor_name":"Mucopolysaccharidosis III","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009084","descriptor_name":"Mucopolysaccharidosis III","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009928","descriptor_name":"Organ Specificity","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014161","descriptor_name":"Transduction, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019076","descriptor_name":"Transgenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023061","descriptor_name":"Gene Order","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1089/hum.2018.189","doi":"https://doi.org/10.1089/hum.2018.189","is_oa":false,"landing_page_url":"https://doi.org/10.1089/hum.2018.189","pdf_url":null,"source":{"id":"https://openalex.org/S39730559","display_name":"Human Gene Therapy","issn_l":"1043-0342","issn":["1043-0342","1557-7422"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy","raw_type":"journal-article"},{"id":"pmid:31020862","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31020862","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human gene therapy","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/e912152c-0f4a-46cd-8421-56a4a5e9cdde","doi":null,"is_oa":false,"landing_page_url":"http://www.scopus.com/inward/record.url?scp=85072746953&partnerID=8YFLogxK","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gray, A L, O'Leary, C, Liao, A, Ag\u00fandez, L, Youshani, A S, Gleitz, H F, Parker, H, Taylor, J T, Danos, O, Hocquemiller, M, Palomar, N, Linden, R M, Henckaerts, E, Holley, R J & Bigger, B W 2019, 'An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA', Human Gene Therapy, vol. 30, no. 9, pp. 1052-1066. https://doi.org/10.1089/hum.2018.189","raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/677134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31020862","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy, vol. 30 (9), (1052-1066)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/e26cffa3-2476-4943-8c60-91e3bbe17574","doi":null,"is_oa":true,"landing_page_url":"https://research.manchester.ac.uk/en/publications/e26cffa3-2476-4943-8c60-91e3bbe17574","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gray, A L, O'Leary, C, Liao, A, Ag\u00fandez, L, Youshani, A S, Gleitz, H F, Parker, H, Taylor, J T, Danos, O, Hocquemiller, M, Palomar, N, Linden, R M, Henckaerts, E, Holley, R J & Bigger, B W 2019, 'An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA', Human Gene Therapy, vol. 30, no. 9, pp. 1052-1066. https://doi.org/10.1089/hum.2018.189","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10074030","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10074030/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Human Gene Therapy , 30 (9) pp. 1052-1066. (2019)","raw_type":"Article"},{"id":"mag:3153779011","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10074030/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/e26cffa3-2476-4943-8c60-91e3bbe17574","doi":null,"is_oa":true,"landing_page_url":"https://research.manchester.ac.uk/en/publications/e26cffa3-2476-4943-8c60-91e3bbe17574","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gray, A L, O'Leary, C, Liao, A, Ag\u00fandez, L, Youshani, A S, Gleitz, H F, Parker, H, Taylor, J T, Danos, O, Hocquemiller, M, Palomar, N, Linden, R M, Henckaerts, E, Holley, R J & Bigger, B W 2019, 'An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA', Human Gene Therapy, vol. 30, no. 9, pp. 1052-1066. https://doi.org/10.1089/hum.2018.189","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2426495403","display_name":"Characterisation of a novel AAV vector with enhanced neurotropism","funder_award_id":"MR/S009302/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W158750202","https://openalex.org/W306267577","https://openalex.org/W1832822495","https://openalex.org/W1966701154","https://openalex.org/W1971793795","https://openalex.org/W1983941630","https://openalex.org/W1994891102","https://openalex.org/W1996706043","https://openalex.org/W2013609666","https://openalex.org/W2018254143","https://openalex.org/W2024990739","https://openalex.org/W2044050006","https://openalex.org/W2067364138","https://openalex.org/W2083921257","https://openalex.org/W2099501269","https://openalex.org/W2101631364","https://openalex.org/W2101765690","https://openalex.org/W2104602213","https://openalex.org/W2110746342","https://openalex.org/W2114065422","https://openalex.org/W2114165048","https://openalex.org/W2118090084","https://openalex.org/W2121309530","https://openalex.org/W2126444128","https://openalex.org/W2126590211","https://openalex.org/W2166739815","https://openalex.org/W2169225250","https://openalex.org/W2171399695","https://openalex.org/W2343880322","https://openalex.org/W2393713187","https://openalex.org/W2484015429","https://openalex.org/W2736152032","https://openalex.org/W2768805525","https://openalex.org/W2786712411","https://openalex.org/W2800131432","https://openalex.org/W2805769253"],"related_works":["https://openalex.org/W2995878785","https://openalex.org/W3021283480","https://openalex.org/W2054096165","https://openalex.org/W2153694181","https://openalex.org/W2757580852","https://openalex.org/W1832822495","https://openalex.org/W2101765690","https://openalex.org/W2083105822","https://openalex.org/W3094186200"],"abstract_inverted_index":{"Patients":[0],"with":[1,92,137,206,242],"the":[2,10,18,123,129,193,199,226,229,235],"lysosomal":[3,11],"storage":[4],"disease":[5],"mucopolysaccharidosis":[6],"IIIA":[7],"(MPSIIIA)":[8],"lack":[9],"enzyme":[12,125,186],"N-sulfoglucosamine":[13],"sulfohydrolase":[14],"(SGSH),":[15],"one":[16],"of":[17,24,28,65,89,116,179,195,209,234],"many":[19],"enzymes":[20],"involved":[21],"in":[22,33,58,80,95,182,185,198,264],"degradation":[23],"heparan":[25,30],"sulfate.":[26],"Build-up":[27],"un-degraded":[29],"sulfate":[31],"results":[32],"severe":[34],"progressive":[35],"neurodegeneration":[36],"for":[37],"which":[38],"there":[39],"is":[40,119],"currently":[41,52],"no":[42],"treatment.":[43,177],"Experimental":[44],"gene":[45,49,118],"therapies":[46],"based":[47],"on":[48],"addition":[50],"are":[51],"being":[53],"explored.":[54],"Following":[55],"preclinical":[56],"evaluation":[57],"MPSIIIA":[59,82,163],"mice,":[60],"an":[61],"adeno-associated":[62],"virus":[63],"vector":[64,221,247],"serotype":[66],"rh10":[67],"designed":[68],"to":[69,101,121,146,162,202,225,238,250],"deliver":[70],"SGSH":[71,124,149,169,196],"and":[72,87,112,168,255],"sulfatase":[73,107],"modifying":[74,108],"factor":[75,109],"1":[76,110],"(SAF301)":[77],"was":[78,135,211,223],"trialed":[79],"four":[81],"patients,":[83],"showing":[84],"good":[85],"tolerance":[86],"absence":[88],"adverse":[90],"events":[91],"some":[93],"improvements":[94],"neurocognitive":[96],"measures.":[97],"This":[98],"study":[99],"aimed":[100],"improve":[102],"SAF301":[103],"further":[104,212],"by":[105],"removing":[106],"(SUMF1)":[111],"assessing":[113],"if":[114,148],"expression":[115,150,170],"this":[117,259],"needed":[120],"increase":[122],"activity":[126],"(SAF301b).":[127],"Second,":[128],"murine":[130],"phosphoglycerate":[131],"kinase":[132],"(PGK)":[133],"promotor":[134,144,189],"exchanged":[136],"a":[138,239],"chicken":[139],"beta":[140],"actin/CMV":[141],"composite":[142],"(CAG)":[143],"(SAF302)":[145],"see":[147],"levels":[151,171],"could":[152],"be":[153,262],"boosted":[154],"further.":[155],"The":[156],"three":[157],"different":[158],"vectors":[159],"were":[160,172],"administered":[161],"mice":[164],"via":[165],"intracranial":[166],"injection,":[167],"compared":[173],"4":[174],"weeks":[175],"post":[176],"Removal":[178],"SUMF1":[180],"resulted":[181],"marginal":[183],"reductions":[184],"activity.":[187],"However,":[188],"exchange":[190],"significantly":[191],"increased":[192,246],"amount":[194],"expressed":[197],"brain,":[200],"leading":[201,249],"superior":[203],"therapeutic":[204],"correction":[205],"SAF302.":[207],"Biodistribution":[208],"SAF302":[210],"assessed":[213],"using":[214],"green":[215],"fluorescent":[216],"protein":[217],"(GFP),":[218],"indicating":[219],"that":[220],"spread":[222],"limited":[224],"area":[227],"around":[228],"injection":[230,236,244],"tract.":[231],"Further":[232],"modification":[233],"strategy":[237],"single":[240],"depth":[241],"higher":[243],"volume":[245],"distribution,":[248],"more":[251],"widespread":[252],"GFP":[253],"distribution":[254],"sustained":[256],"expression,":[257],"suggesting":[258],"approach":[260],"should":[261],"adopted":[263],"future":[265],"trials.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2941650108","counts_by_year":[{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-05-03T00:00:00"}
